PureHealth reported net profit of USD 337 million for the first half of 2026, alongside higher revenue and stronger operating performance. The company said group revenue climbed 9% year on year to USD 4.0 billion.
According to the update, the top-line growth was supported by a larger contribution from international operations and resilient results across its insurance business. International operations accounted for 33% of total group revenue during the period, highlighting their growing role in the company’s overall mix.
PureHealth also reported a 24% increase in EBITDA in the first half, pointing to improved operating momentum as revenue expanded. The combination of revenue growth and stronger EBITDA suggests the group delivered a healthier earnings profile in the opening six months of 2026.
The latest H1 2026 results indicate that PureHealth is benefiting from both geographic diversification and stable performance in insurance. With international operations representing a significant share of revenue, the company’s first-half numbers show how overseas business and core insurance activity helped drive overall growth.
